|
a/b-globin
mRNA ratio |
227 |
|
antibacterial
effect |
1 |
|
|
a-iduronidase |
214 |
|
antibodies |
108 |
|
|
a-thalassemia |
338 |
|
antibody
formation |
100 |
|
|
9-anilinoacridine |
217 |
|
antibody |
260 |
|
|
A.
lumbricoides |
291 |
|
Antibody’s
reactivities |
197 |
|
|
Abdominal
Circumference |
113 |
|
antifolate
binding |
222 |
|
|
Abdominal
tergel scales |
276 |
|
antifolate
resistance |
220 |
|
|
Abdominal |
39 |
|
antifungal
activity |
178-179,
184 |
|
|
Abduccens
nucleus |
358 |
|
antigenemia |
202 |
|
|
abducens
palsy |
120 |
|
antiherpes
activity |
182 |
|
|
aberrant
splice site |
342 |
|
anti-HIV
in urine |
109 |
|
|
ABL |
22 |
|
anti-HIV |
109 |
|
|
Abnormal
Hb |
212 |
|
antimalaria |
21 |
|
|
Abnormal
hemoglobin |
211,
336 |
|
antimalarial
antibodies |
291 |
|
|
Abnormal
uterine bleeding |
41 |
|
antimalarial
drug development |
221 |
|
|
absolute
himidity |
30 |
|
antimalarial
drug |
226,
266 |
|
|
absorption |
330 |
|
antimalarials |
268 |
|
|
Acanthamaeba |
131 |
|
antimicrobial
activities |
179 |
|
|
Acanthamoeba
spp. |
23 |
|
antimicrobial
activity |
184 |
|
|
acanthosis
nigrica diabetes |
65 |
|
Antimicrobial
resistance |
54-55 |
|
|
acetlycholinesterase |
80,
276 |
|
Antimicrobial
susceptibility |
103-104 |
|
|
Acinetobacter
calcoaceticus |
345 |
|
Antimutagemicity |
323-326 |
|
|
acquired
immunodeficiency syndrome |
351 |
|
antiosicant
enzymes |
250 |
|
|
Active
management |
45 |
|
antiotensin-
II |
355 |
|
|
Active
transport |
251 |
|
antioxidant
nutrients |
43 |
|
|
actrsome
reaction |
209 |
|
Antioxidant
status |
66 |
|
|
acute
renal failure |
265 |
|
Antioxidant |
179-180 |
|
|
Acute
respiratory tract infection |
104 |
|
Antiretroviral
drugs |
155 |
|
|
acute
toxicity |
188 |
|
Antiretroviral
treatment |
154 |
|
|
additive |
326 |
|
antisense
therapy |
342 |
|
|
administration
and dosage |
100 |
|
anxiety
scale |
29 |
|
|
Adult |
297-300 |
|
anxiety |
29 |
|
|
Adverse
drug reaction monitoring report |
195 |
|
Anxiolytic
profiles |
246 |
|
|
Aedes
aegypti |
276-277,
347, 349 |
|
APACHE
III |
265 |
|
|
Aedes
togoi |
275 |
|
aphasia |
52 |
|
|
aflatoxin |
326 |
|
apical
rotation |
48 |
|
|
age |
24 |
|
Apoptosis |
251,
335 |
|
|
Agricultural
Insecticide |
156 |
|
arachidonic
acid |
147 |
|
|
AIDS |
18,
132, 155 |
|
Arbovirus |
347 |
|
|
air
sampling |
161 |
|
argininosuccinate
synthetase |
213 |
|
|
airway |
30 |
|
ARI |
194 |
|
|
alanine |
330 |
|
Arteether |
302 |
|
|
Albendazole |
295 |
|
Artemisia
annua |
277 |
|
|
alcoho
extraction |
322 |
|
artemisinin
derivatives |
259 |
|
|
Alcohol |
87 |
|
artemisinin
effect |
261 |
|
|
alfentanil |
29 |
|
artemisinin |
218,
298-299, 302 |
|
|
alkali
extraction |
322 |
|
Arteries |
89 |
|
|
alkyl
glucoside |
212 |
|
artesunate |
23,
241, 298-299 |
|
|
ALL |
21,
23 |
|
artesunate-mefloquine |
261,
264 |
|
|
Allelic
isoenzymes |
315 |
|
ascaris |
259 |
|
|
Allergic
Rhinitis |
51 |
|
Ascorbic
acid |
162,
323 |
|
|
aloe
preparation |
188 |
|
ASEANFOODS |
321 |
|
|
Aloe
vera |
65,
188 |
|
Asia |
155 |
|
|
Alpha
and Beta Waves |
354 |
|
asian
foods |
30 |
|
|
alpha2-adrenoceptor |
248 |
|
Aspirin |
174 |
|
|
amenorrhea |
37 |
|
asthmatic
attack |
35 |
|
|
ames
test |
324-326 |
|
astrocytoma |
149 |
|
|
Aminoglycoside |
54 |
|
Atenolol |
91 |
|
|
aminopyrene |
324,
326 |
|
atherosclerosis |
247 |
|
|
AML |
21 |
|
atherosclerotic
plague |
247 |
|
|
amniotic
fluid |
115 |
|
athlete |
330 |
|
|
Amopheles
dirus |
204 |
|
atimutagenicity |
323 |
|
|
amorphization |
176 |
|
Atrial
Septal Defect |
136 |
|
|
Amoxicillin |
145 |
|
attributable
fractions (AF%) |
288 |
|
|
amphotericin
B |
100,
176 |
|
autogenous
subcolony |
275 |
|
|
anabolic-androgenic
steroid drugs |
325 |
|
automated
cell counter |
19 |
|
|
Analgesia |
77,
80 |
|
automated
cell counting |
21 |
|
|
Analgesic
Tecnhique |
77,
80 |
|
Automated
DNA sequencing |
146,
360 |
|
|
Analytical
and Clinical Performance |
84 |
|
automatic
analyzer |
20 |
|
|
anemia |
98,
298 |
|
automatic
cell analyzer |
18 |
|
|
Anesthesia |
73,
77 |
|
autoregulation |
147 |
|
|
Angina |
154 |
|
Ava
II Polymorphism |
81 |
|
|
Angioplasty |
89 |
|
availability |
162 |
|
|
Angiostrongylus
cantonensis |
203 |
|
avoidable
burden |
289 |
|
|
animal
products |
319 |
|
|
|
|
|
